FDA Inspection 854753 — Tianjin Kingyork Pharmaceuticals Co., Ltd

Tianjin Kingyork Pharmaceuticals Co., Ltd — FEI 3013844768

The FDA completed an inspection of Tianjin Kingyork Pharmaceuticals Co., Ltd on Jul 5, 2013 in Tianjin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 5, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tianjin (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.